ListarArtículos (Medicina) por materia "Lanifibranor"
Mostrando ítems 1-1 de 1
-
Artículo
A randomized, controlled trial of the pan-PPAR agonist lanifibranor in NASH
(Massachusetts Medical Society, 2021)BACKGROUND Management of nonalcoholic steatohepatitis (NASH) is an unmet clinical need. Lanifibranor is a pan-PPAR ...